Medtronic · 1 hour ago
Senior Financial Analyst – MiniMed Americas Controllership (U.S. & Canada)
Medtronic is a global leader in healthcare technology, dedicated to addressing challenging health problems. The Senior Financial Analyst will support accounting and financial reporting activities for the MiniMed commercial and operational entities across the U.S. and Canada, ensuring compliance with US GAAP and internal controls.
Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical Device
Responsibilities
Deliver timely month-end, quarter-end, and year-end close activities for U.S. and Canada MiniMed entities in accordance with US GAAP
Prepare, review, and analyze journal entries, account reconciliations, and balance sheet roll-forwards, ensuring accuracy, completeness, and appropriate support
Support statutory and management reporting requirements for Americas legal entities, including coordination of statutory financial statements and filings where applicable
Compile and analyze legal-entity financial information to support consolidated reporting, variance analysis, and management review
Partner with Corporate Consolidations to support intercompany accounting, eliminations, and alignment of entity-level results to consolidated financials
Support internal and external audit activities, including preparation of audit support, responses to inquiries, and coordination with auditors and advisors
Execute and support SOX and internal control requirements, including control execution, documentation, testing, and remediation
Support legal-entity fiduciary responsibilities for U.S. and Canadian entities, including governance, compliance, and documentation requirements
Provide accounting support for commercial, operational, and intercompany transactions impacting the Americas region
Assist with technical accounting research and implementation of new accounting standards or policy updates impacting the Americas entities
Drive continuous improvement initiatives focused on close efficiency, standardization, data quality, and process automation
Support Diabetes division separation activities, including Day-1 readiness and post-Day-1 stabilization for the Record-to-Report workstream
Qualification
Required
Bachelor's degree and 4+ years of experience as a financial analyst, accountant, business analyst, or in a related field
OR
Advanced degree and 2+ years of experience as a financial analyst, accountant, business analyst, or in a related field
Preferred
4+ years of progressive accounting or controllership experience, preferably supporting commercial or operational entities
Working knowledge of US GAAP
Strong analytical and problem-solving skills with a high attention to detail and accuracy
Ability to clearly communicate accounting and financial information to cross-functional stakeholders
Working knowledge of SAP and OneStream
Experience working in a transformation-driven or newly public environment
CPA or MBA preferred
Benefits
Health, Dental and vision insurance
Health Savings Account
Healthcare Flexible Spending Account
Life insurance
Long-term disability leave
Dependent daycare spending account
Tuition assistance/reimbursement
Simple Steps (global well-being program)
Incentive plans
401(k) plan plus employer contribution and match
Short-term disability
Paid time off
Paid holidays
Employee Stock Purchase Plan
Employee Assistance Program
Non-qualified Retirement Plan Supplement (subject to IRS earning minimums)
Capital Accumulation Plan (available to Vice Presidents and above, or subject to IRS earning minimums)
Company
Medtronic
Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.
H1B Sponsorship
Medtronic has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (349)
2024 (387)
2023 (291)
2022 (310)
2021 (300)
2020 (261)
Funding
Current Stage
Public CompanyTotal Funding
$18.16BKey Investors
NHS EnglandBlackstone Life SciencesTrade Capital Funding
2025-09-15Post Ipo Debt· $1.76B
2024-05-29Post Ipo Debt· $3.24B
2023-03-23Post Ipo Debt· $2B
Leadership Team
Recent News
Bizjournals.com Feed (2025-11-12 15:43:17)
2026-01-23
Company data provided by crunchbase